Morgan Stanley’s Pactiv Evergreen PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-154,118
Closed -$2.78M – 8384
2025
Q1
$2.78M Sell
154,118
-32,699
-18% -$581K ﹤0.01% 4397
2024
Q4
$3.26M Sell
186,817
-6,104
-3% -$82.6K ﹤0.01% 4332
2024
Q3
$2.22M Sell
192,921
-168,246
-47% -$1.93M ﹤0.01% 4572
2024
Q2
$4.09M Sell
361,167
-313,373
-46% -$4.17M ﹤0.01% 4045
2024
Q1
$9.7M Sell
674,540
-3,124,375
-82% -$44.3M ﹤0.01% 3374
2023
Q4
$52.1M Buy
3,798,915
+297,392
+8% +$3.13M ﹤0.01% 1679
2023
Q3
$28.5M Sell
3,501,523
-9,856
-0.3% -$80.6K ﹤0.01% 2089
2023
Q2
$26.6M Buy
3,511,379
+21,080
+0.6% +$161K ﹤0.01% 2175
2023
Q1
$27.9M Buy
3,490,299
+33,370
+1% +$343K ﹤0.01% 2082
2022
Q4
$39.3M Buy
3,456,929
+3,380,554
+4,426% +$36.9M ﹤0.01% 1706
2022
Q3
$666K Sell
76,375
-24,922
-25% -$259K ﹤0.01% 5115
2022
Q2
$1.01M Buy
101,297
+34,081
+51% +$343K ﹤0.01% 5009
2022
Q1
$677K Buy
67,216
+885
+1% +$9.41K ﹤0.01% 5221
2021
Q4
$841K Buy
66,331
+38,499
+138% +$501K ﹤0.01% 5197
2021
Q3
$348K Buy
27,832
+13,777
+98% +$187K ﹤0.01% 5702
2021
Q2
$212K Buy
14,055
+10,780
+329% +$162K ﹤0.01% 5985
2021
Q1
$45K Sell
3,275
-68,896
-95% -$1.07M ﹤0.01% 6394
2020
Q4
$1.31M Buy
72,171
+12,145
+20% +$187K ﹤0.01% 4492
2020
Q3
$762K Buy
+60,026
New +$753K ﹤0.01% 4400

Morgan Stanley's PTVE Position: Q2 2025 in Review

Morgan Stanley sold out of Pactiv Evergreen (PTVE) in Q2 2025, closing a stake of 154,118 shares — an estimated $2.78M sold.

Morgan Stanley first reported a position in PTVE in Q3 2020 and held it in 19 quarters. The position peaked at $52.1M in Q4 2023. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

  • Morgan Stanley reported no remaining Pactiv Evergreen position as of Q2 2025 after selling out during the quarter.
  • Morgan Stanley sold 154,118 Pactiv Evergreen shares in Q2 2025, an estimated $2.78M.
  • Morgan Stanley first reported a position in Pactiv Evergreen in Q3 2020 and held it in 19 quarters.
  • Morgan Stanley's Pactiv Evergreen position peaked at $52.1M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Pactiv Evergreen as of Q2 2025.

Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.